HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc.
Previous close
$4.65
Day range
$4.17 - $4.91
Year range
$2.70 - $10.25
Market cap
239.05M USD
Avg Volume
185.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 7.81M | -55.33% |
Operating expense | 30.40M | -7.25% |
Net income | -19.12M | -33.30% |
Net profit margin | -244.90 | -198.40% |
Earnings per share | -0.31 | 8.82% |
EBITDA | -23.12M | -42.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 267.40M | 2.89% |
Total assets | 308.37M | -1.61% |
Total liabilities | 336.66M | -9.21% |
Total equity | -28.29M | — |
Shares outstanding | 55.59M | — |
Price to book | -9.12 | — |
Return on assets | -18.72% | — |
Return on capital | -319.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.12M | -33.30% |
Cash from operations | -21.00M | 22.80% |
Cash from investing | -61.32M | -259.57% |
Cash from financing | 1.05M | -24.22% |
Net change in cash | -81.27M | -744.84% |
Free cash flow | -5.30M | 49.52% |
About
Founded
2015
Website
Employees
116
